Stock of the Day

September 11, 2024

Ares Capital (ARCC)

$19.17
-$0.04 (-0.2%)
Market Cap: $13.76B

About Ares Capital

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Today's Trend

Ares Capital Corporation (ARCC): Shares are trading higher after recent coverage showed resilience in the private‑credit market and continued investor interest in ARCC’s high yield. Fundraising strength at parent Ares Management and ARCC’s quarterly commentary that exposure to software loans poses limited stress appear to be supporting the stock, though analyst price‑target trims and a slight quarterly earnings miss add caution.

Recent News